Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven F Dowdy

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Nature Biotechnology|March 1, 2017
Overcoming cellular barriers for RNA therapeuticsSteven F Dowdy
The New England Journal of Medicine|July 18, 2019
Controlling CRISPR-Cas9 Gene EditingSteven F Dowdy
RNA (New York, N.Y.)|January 20, 2023
Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?Steven F Dowdy
Cell|November 18, 2006
The anonymous American Idol manuscript reviewerSteven F Dowdy
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Another twist in the transforming growth factor beta-induced cell-cycle arrest chronicleCatherine Denicourt, Steven F Dowdy
Cell Cycle (Georgetown, Tex.)|January 22, 2010
Efficient siRNA delivery by novel PTD-DRBD fusion proteinsAkiko Eguchi, Steven F Dowdy
Current Pharmaceutical Design|November 13, 2012
PTD/CPP peptide-mediated delivery of siRNAsAsaf Presente, Steven F Dowdy
Plos One|July 28, 2017
Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNANaohisa Yoshioka, Steven F Dowdy
Nucleic Acid Therapeutics|May 22, 2018
RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal EscapeSteven F Dowdy, Matthew Levy
Nucleic Acid Therapeutics|November 6, 2015
Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene EditingManuel Kaulich, Steven F Dowdy
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Nature Biotechnology|March 1, 2017
Overcoming cellular barriers for RNA therapeuticsSteven F Dowdy
The New England Journal of Medicine|July 18, 2019
Controlling CRISPR-Cas9 Gene EditingSteven F Dowdy
RNA (New York, N.Y.)|January 20, 2023
Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?Steven F Dowdy
Cell|November 18, 2006
The anonymous American Idol manuscript reviewerSteven F Dowdy
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Another twist in the transforming growth factor beta-induced cell-cycle arrest chronicleCatherine Denicourt, Steven F Dowdy
Cell Cycle (Georgetown, Tex.)|January 22, 2010
Efficient siRNA delivery by novel PTD-DRBD fusion proteinsAkiko Eguchi, Steven F Dowdy
Current Pharmaceutical Design|November 13, 2012
PTD/CPP peptide-mediated delivery of siRNAsAsaf Presente, Steven F Dowdy
Plos One|July 28, 2017
Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNANaohisa Yoshioka, Steven F Dowdy
Nucleic Acid Therapeutics|May 22, 2018
RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal EscapeSteven F Dowdy, Matthew Levy
Nucleic Acid Therapeutics|November 6, 2015
Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene EditingManuel Kaulich, Steven F Dowdy
Pageof 10